Genomic profiling, also known as molecular profiling, enables oncologists to analyze the genetic alterations driving a patient’s cancer and tailor treatment strategies accordingly. By sequencing the DNA of tumor cells, researchers can identify specific mutations, gene amplifications, and chromosomal rearrangements to cancer development and progression.
As genomic profiling technologies continue to advance, the era of precision oncology is transforming cancer care, offering new hope for improved outcomes and quality of life for cancer patients.